SPONSOR
baotai Liang
Total Trials
3
Recruiting
3
Phases
Phase 2
baotai Liang is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Prostate Cancer, Prostate CA.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — baotai Liang
How many clinical trials has baotai Liang sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by baotai Liang, of which 3 are actively recruiting participants. These trials cover conditions including Prostate Cancer, Prostate CA. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does baotai Liang research focus on?
baotai Liang clinical trials span Prostate Cancer, Prostate CA. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a baotai Liang clinical trial?
To participate in a baotai Liang trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all baotai Liang trials with current recruitment status updated daily.
Clinical Trials by baotai Liang
NCT07163910 Phase 2
Recruiting
Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study
Prostate Cancer
NCT06834321 Phase 2
Recruiting
Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer
Prostate CA
NCT07250542 Phase 2
Recruiting
A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology